C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/12/2002	WO2002062972A3 Hybridoma cell line g250 and its use for producing monoclonal antibodies
12/12/2002	WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002	WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002	WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002	WO2002046232A3 Multimeric single-chain antibody with multiple antigen binding
12/12/2002	WO2002045742A3 Lipoteichoic acid immunogenic compositions and methods of making and using thereof
12/12/2002	WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same
12/12/2002	WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002	WO2002018557A3 Human kinases
12/12/2002	WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002	WO2002002775A3 Calpain protease 12
12/12/2002	WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002	WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002	WO2001038360A9 Novel hcv non-structural polypeptide
12/12/2002	WO2001012816A9 Porcine endovirus gag and env and diagnostic uses thereof
12/12/2002	US20020188411 Portable, self-contained data collection systems and methods
12/12/2002	US20020188106 Tau protein epitopes for use in the treatment of alzheimer's disease
12/12/2002	US20020187993 Bifunctional energy-reversible acyl-compositions
12/12/2002	US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187517 Monoclonal antibodies to Sarcocystis neurona and uses therefor
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002	US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
12/12/2002	US20020187153 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
12/12/2002	US20020187152 Administering a drug which can selectively kill Fusobacterium varium cells, or a drug which can neutralize the toxin produced by Fusobacterium varium cells; vaccines, diagnosis, screening
12/12/2002	US20020187150 Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
12/12/2002	US20020187149 Activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptible carrier.
12/12/2002	US20020187148 T cell receptor ligands and methods of using same
12/12/2002	US20020187146 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
12/12/2002	US20020187145 Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
12/12/2002	US20020187144 Useful for treating patients with colorectal cancer and gastric carcinomas; particularly useful for treating patients who have tumors that are resistant to one or more chemotherapeutic agents and/or have metastasized.
12/12/2002	US20020187142 Crosslinking of these receptors with a bispecific molecule of the invention would lead to inhibition of the release of allergic mediators and amelioration of the symptoms of allergic diseases.
12/12/2002	US20020187141 Composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent; determination whether the failure of traditional chemotherapy is due to multidrug resistant tumor cells
12/12/2002	US20020187140 Two novel human cathepsin proteins
12/12/2002	US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002	US20020187100 Preferably the antibody is monoclonal antibody 81C6 or an antibody that binds to the epitope bound by monoclonal antibody 81C6.
12/12/2002	CA2449890A1 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002	CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002	CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449132A1 Recombinant antibodies against infectious bursal disease virus (ibdv)
12/12/2002	CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2447695A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002	CA2445099A1 Method to measure gene expression ratio of key genes
12/11/2002	EP1264890A2 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/11/2002	EP1264885A1 Antibody library
12/11/2002	EP1264598A1 Altering an immune response by influencing the interaction of LAIR with its ligand
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263970A1 Identification of a dual specificity phosphatase: dusp-10
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263957A2 Human lipid binding protein 1
12/11/2002	EP1263956A2 Human genes and gene expression products
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263951A2 Transcription activator of the cited family
12/11/2002	EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002	EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263938A1 Udp-galactose: beta-d-galactose-r 4-alpha-d-galactosyltransferase, alpha4gal-t1
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263790A1 Monoclonal antibodies to the human ldl receptor, their production and use
12/11/2002	EP1263789A2 Antibody inhibiting the binding between gp120 and dc-sign and screening methods
12/11/2002	EP1263787A2 G-protein coupled receptors
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002	EP1263782A2 Leafy cotyledon2 genes and their uses
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263779A1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells
12/11/2002	EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
12/11/2002	EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002	EP1263450A1 Method and apparatus for inducing a cellular response
12/11/2002	EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP0591431B1 Hepatitis c virus (hcv) polypeptides
12/11/2002	CN1384886A Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
12/11/2002	CN1384840A Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
12/11/2002	CN1384839A Redox reversible HCV proteins with native-like conformation
12/11/2002	CN1384225A Ferro-nickel alloy electroplating process for copper plate working surface of continuously casting crystallizer
12/11/2002	CN1384196A Coding sequence and application of konjaku agglutinic protein
12/11/2002	CN1384120A Specific antibody to active liver growth factor activator and method using the same
12/11/2002	CN1384119A Composite yolk antibody for resisting fowl's viral blight and its prepn and application
12/11/2002	CN1384114A Growth promoting factor and its prepn and use
12/11/2002	CN1384103A Carbofuran half-antigen, antigen and antibody and their prepn process
12/10/2002	US6492577 Nucleic acids are useful in targeting gene expression to embryos or in modulating embryo development in plants
12/10/2002	US6492511 Isolation and identification of novel polymerases
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein

1 ... 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 ... 1494